Coca-Cola's (NYSE: KO) products are ubiquitous the world over, with operations in over 200 countries and territories. It has long been a core holding within the Berkshire Hathaway stock portfolio ...

Coca-Cola (NYSE: KO) has been having a banner year. After trailing the market for most of the past three decades, it's beating the market in 2025, up 15% at the time of this writing, while the S&P ...

It's been an interesting year so far for the stock market, to say the least, and in an unusual occurence, Coca-Cola (NYSE: KO) stock is absolutely crushing it. Investors are loving its rock-solid ...

Coca-Cola has been doing a fabulous job of generating sales, despite what's been a wild few years. CEO James Quincey came on board in 2018, just in time to get the company into better shape before ...

Coca-Cola’s current share price of $71.77 trades 3.5% below its recent 52-week high mark of $74.38. Also, the KO stock trades 18.4% above its 52-week low of $60.62.

Coca-Cola is bringing back a beloved Diet Coke flavor, and fans are dying to get their hands on it. On Tuesday, a spokesperson for The Coca-Cola Company confirmed to The Independent that Retro ...

Aggravated Coca-Cola fans are claiming the key to company cost-cutting is less carbonation. Nearly 100 Reddit users claimed they noticed an unacceptable difference in the soda's 'fizziness', which ...

Coca Cola stock price quote NYSE: KO stock, historical charts, related news, stock analyst insights and more to help you make the right investing decisions.

Challenging Coca-Cola & PepsiCo: Reliance to invest up to Rs 8,000 crore in Campa, beverages expansion over next 15 months TOI Business Desk / TIMESOFINDIA.COM / Jun 19, 2025, 15:04 IST ...

The second soft drink the Coca-Cola Company introduced was Fanta Orange, which came to Naples, Italy, in 1955. Fanta hit U.S. shelves in 1960, a year before Sprite came out.

Stock image of a person holding a glass of sparkling water. Getty Images What To Know The recall began on May 28, 2025, and was initiated by The Coca-Cola Company. The FDA issued the Class II risk ...